DSPE-PEG1000-NYZL1
DSPE-PEG1000-NYZL1 is a PEG compound which composed of DSPE and a NYZL1 peptide. NYZL1 can specifically bind to bladder cancer tissues and cells. DSPE-PEG1000-NYZL1 can be used for drug delivery[1].
Product Specifications
UNSPSC
12352200
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Mal-Cys-NYEL]C(CCOCCOC(NCCOP(OC[C@](COC(CCCCCCCCCCCCCCCCC)=O)([H])OC(CCCCCCCCCCCCCCCCC)=O)(O)=O)=O)=O.[n]
Molecular Weight
1000 (Average)
References & Citations
[1]Yang Y, et al. CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer. Mol Ther Oncolytics. 2022 Jan 1;24:319-330.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15309283 1 Vial
Lentiviral human CDK8 shRNA (UAS) - Lentiviral human CDK8 shRNA (UAS, iRFP) plasmid
Ask
View Details 
356793-01 48 Tests
IL2RB (Interleukin-2 receptor subunit beta) BioAssayTM ELISA Kit (Human) discontinued
Ask
View Details